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Proteins and Their Peptide Motifs in Acellular Apatite
Mineralization of Scaffolds for Tissue Engineering
Johan Benesch, Ph.D.,1,2 Joa˜o F. Mano, Ph.D.,1,2 and Rui L. Reis, Ph.D.1,2
Many proteins in the inorganic=organic matrix of bone induce or modulate or inhibit mineralization of apatite
in vivo. Many attempts have been made to mimic and understand this mechanism as part of bone formation, and
ectopic mineralization and control thereof. Many attempts have also been made to use such proteins or protein
fragments to harness their potential for improved mineralization. Such proteins and peptide motifs have also been
the inspiration for attempts of making mimics of their structures and motifs using chemical or biological syn-
thesis. The aim of this review is to highlight how proteins and (poly)peptides themselves impact mineralization
in the human body, and how those could be used and have been used for improving apatite mineralization, for
example, on or in materials that by themselves do not induce apatite mineralization but otherwise have inter-
esting properties for use as bone tissue engineering scaffolds.
Introduction
With the aim of making new bone or replacing dam-aged bone, many venues have been chosen in the past.
With the advent of ideas that aim to enable us to replace
damaged bone without resorting to metallic implants, there
is a need for materials and procedures that will comply with
the requirements for clinical success. For bone tissue engi-
neering applications, it is important to develop scaffolds that
are both degradable and can induce apatite formation. The
overall goal should always be to achieve the three O’s of
bone growth and repair: osteoinduction, osteoconduction, and
osteogenesis.1 Because hydroxylapatite self-induces further
hydroxylapatite formation,2–4 it may be a good starting point
to coat the scaffolds with a thin layer of apatite for the
scaffold to be successful. A large range of inorganic chemical
modification (e.g., using silicate treatments) strategies draw-
ing inspiration from the Nature for coating biomaterials with
calcium phosphates in vitro have been attempted.5 Indeed, it
has been claimed that the essential requirement for an arti-
ficial material to bond to living bone is the presence of ap-
atite or the formation of biologically active bone-like apatite
layer on their surfaces,6 although highly crystalline stoi-
chiometric hydroxylapatite is probably not the best option
for tissue-engineered constructs because of its low solubility.7
One should note that cells bind to the implanted structures
rather than implants binding to bone.8
However, there may not be enough autogenous bone or of
inferior quality because of the health status of the patient to
make this a viable option,1 and since xeno- or allografts usu-
ally are advised against because of the risk of transmitting
disease agents, the use of autograft is usually recommended
for bone repair.1 In this context, proteins or synthetic poly-
peptides have been suggested for induction of mineralization
of constructs that are aimed at replacing damaged or weak-
ened bone.
Because there are some differences in how the protein based
mechanisms for acellular mineral nucleation and growth,
many have suggested that there are two classes of inhibitors:
those that affect nucleation and those that affect crystal
growth.9,10 One would expect that promoters in analogy also
can be divided into two classes. Perhaps, surprisingly we
shall note that some proteins can be either inhibitor or pro-
moter depending on not only its state but also experimental
parameters. For in vitro experiments this can also be influ-
enced by experimental factors such as biopolymer and ion
concentration, and pH. Thus, it is important to learn from the
Nature how proteins and peptide motifs are used in vivo to
induce nucleation and growth, and how they can be used to
induce an appropriately formed apatite. In this review we will
not focus on the cellular actions.11–14
Many proteins both in the extracellular matrix (ECM) and
in blood will affect the mineralization as noted in the existing
very wide and large literature. One would thus expect that
it is very appealing to learn from the Nature how the mimics
of the organic components in bone can be used to control
mineral formation by learning how these modulate both the
initial nucleation and the following crystal growth.
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This review aims to give a brief introduction to apatite and
the proteins involved in mineralization followed by a more
extensive account of how proteins themselves directly can in-
fluence mineralization of apatite and how that has been used
to induce and modulate apatite formation for biomaterials
and bone tissue engineering applications.
Apatites in Bones
There has been some debate whether the apatite in bone is
hydroxyl apatite or carbonate apatite, although the apatite
found in human bone is most likely poorly crystalline carbo-
nated apatite with some hydroxyl character.15–19 The inor-
ganic phase of bone is apatite with different crystal size and
substituents depending on when and where it is formed.20
The first woven bone is biodegraded and replaced with la-
mellar bone that is more structured.11,21
It is not always clearly demonstrated which type of apatite is
formed in the in vitro or in vivo experiments because often only
the Ca=P-ratio, but neither the hydroxyl nor carbonate content,
is determined. Thus, in this review the formed mineral in the
referenced studies is in many cases simply referred to as apa-
tite (at least when the determined Ca=P ratio is between 1.6
and 2). Below that the formed pure calcium phosphate may not
be apatitic15 but can be apatitic if Ca is partially substituted
with Mg and other metals so that (CaþMe)=P> 1.6.
The Proteins
Many proteins have multiple functions, so it is not sur-
prising that a mineralization-related protein may have mul-
tiple functions in mineralization.21–37 Overall, many of the
mineralization-related proteins are acidic and phosphorylated.
Some proteins contain dicarboxylic acids. Notably, dentin
phosphoprotein contains 37% aspartic acid and 38% serine.38
Three of four amino acids are Asp and PSer motifs such as
PSer-Asp-PSer-Asp, Asp-X-Asp-Y, and PSer-W-PSer-Z, where
X–Z may also be Asp or Ser.39 And phosphoryns have multi-
ple repeats of Asp-Ser-Ser40 of which the serines often are
phosphorylated. These findings suggest that alternating rather
than homopolypeptides are important during mineralization
in terms of calcium coordination, and apatite binding and
modulation.
The differences in distribution of all these protein indicate
that they have different roles in both space (specific tissues,
see Table 1) and time,20,41–45 because they are expressed with
different timing during bone formation. But all proteins are
not exclusively associated with bone; for example, biglycan
and decorin are found both in bone and cartilage, although
their glycosylation varies between tissues.46 And others that
prevent mineralization are not found in bone; for example,
saliva contains statherin.47,48 (See Table 1 for an overview of
the tissue distribution of these proteins and a tentative sum-
mary of their roles in mineralization.) Collagen is the major
protein in bone11,21 but does not necessarily nucleate apatite
in vivo.49 Hence, one would assume that the noncollagenous
bone proteins regulate bone mineralization50 although the
orientation of the collagen fibrils is important for the orga-
nization of the formed bone.11,51
Protein Binding to Apatite
Many proteins will bind from blood plasma to hydroxyl-
apatite.52 In fact, the wide difference in the ability of proteins
to adsorb to apatite has been used in protein separation
techniques since the 1950s.53 The binding of proteins to ap-
atite depends on their isoelectric point.54,55 Clusters of car-
boxyl groups (rather than total amount of negative charges)
strengthen protein binding to hydroxylapatite.55 The dicar-
boxyl on Gla in bone Gla protein makes it bind stronger to
apatite than to amorphous calcium phosphates.56 Gla has
also been shown to be vital for osteocalcin and oligopeptide
mimic to bind to apatite.50,57,58
For N-terminal fragments of statherin, it is the sequence,
conformation, and the total charge rather than the chemical
groups that are important for its binding behavior to apa-
tite.48 The sign of the charge is also important as demonstra-
ted by the higher affinity48,59 to and lower elutability60 from
apatite of negatively charged proteins compared to positively
charged proteins (at physiological pH).
A number of amino acid sequences with three carboxyls
and=or phosphates have been identified and stipulated to
have a role in the binding of phosphoryn to apatite.61 A Glu-
rich region in osteonectin and bone sialoprotein and Gla in
proline-rich salivary proteins have been suggested as being
responsible for the binding to apatite.62–64
On the other hand, for some apatite-binding proteins only
one or two phosphoserine residues are enough to increase
their adsorption on apatite.65 But it has been noted that at
least three amino acids are necessary to span one apatite unit
cell.62 Just the presence of a long charged sequence does not
necessarily mean that it is readily available for binding of
calcium for either apatite nucleation or protein binding to
apatite. The conformation of the polypeptide or more spe-
cifically the structure of the carboxylated and=or phos-
phyrolated amino acids could be just as important.40 Part of
the function could be lattice matching between mineral and
polymer,66–69 which is supported by data on alternating ar-
rangements of charged domains on enamel crystal surfaces.70
Note the dimensions of the unit cell of HA: a¼ b¼ 9.4 A˚, and
c¼ 6.9 A˚.69
Similar results were recently noted from X-ray diffraction
(XRD) data on porcine osteocalcin that yielded a good peri-
odic match between five Ca ions bound at three Gla at
consecutive a-helix turns and Ca positions at the face parallel
with the c-axis of hydroxylapatite.57 A synthetic oligopeptide
mimicking this Gla containing a-helix yielded good binding
at the (100) face of hydroxylapatite, which was strongly de-
pendent on the g-carboxylation of Glu.58
Also homopolypeptides such as poly-Glu can be used to in-
duce nanocrystalline apatite.71 However, as already mentioned,
many phosphoproteins use alternating peptide sequences for
binding to apatite and modulating apatite growth. This, again,
stresses the role of conformation of polypeptides in relation to
mineralization. The dimensions of the formed b-sheet are im-
portant because it probably is better if it matches the lattice
dimensions of the mineral surface that is to be encouraged.72
For example, the periodicity of poly-Asp is 6.7–6.9 A˚ and
would fit the c-direction of the (100) surface of octacalcium
phosphate (OCP) (6.87 A˚). Also, the modeling of binding of
oligopeptides to apatite or OCP indicated a better fit for b-
strands comprising PSer-Asp or Pser-Pser-Asp rather than just
repeats of either PSer or Asp.67 This could point at differences
in the roles of electrostatic interaction and chelation in miner-
alization. But then carboxylated b-sheets can be induced or
stabilized by Ca2þ binding73 or adsorption to apatite.58
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It is also important to note that apatite is known to activate
both the coagulation74,75 and the complement76,77 systems.
On the other hand, activation of bodily defense systems via
the complement and coagulation systems has been implied
to play a positive role in osseointegration.78
Proteins and Apatite Formation
The organic components of the ECM are important for both
starting the mineralization by acting as seeds, and control of
the growth of the crystals by influencing the density of seeds,
and the orientation and organization of the formed crys-
tals79,80 or acting as inhibitors.81 In many cases they also
contribute to the strength of and stabilize the mineralized
tissue.79 Apatite crystals have been detected in the grooves
and channels of collagen type I.51,82 Apatite does not nor-
mally form on collagen by itself in vivo although one can
grow minerals on it in vitro.83 Further, the carbonate apatite
structure is tuned by the organization of the collagen type I
network.24,51
The accumulation of (bone and dentine) sialoproteins in
bone and dentine suggests that they have a role in the apatite
mineralization in vivo.63,84 Bone sialoprotein is highly phos-
phorylated and rich in polyglutamic regions. Dentin sialo-
protein is similar but is low in phosphorylation. Bone
sialoprotein is an effective apatite nucleator in vitro84,85 in
hydrogels, whereas dentin sialoprotein has a much lower
affinity for apatite and only has a small effect on nucleation
and growth.84 Glutamic acid (Glu)–rich regions have been
attributed to the nucleation properties of bone sialoprotein.86
As reviewed by Boskey, phosphophoryn and bone sialo-
protein can be both nucleators and inhibitors28 of apatite
mineralization.
Osteocalcin adsorbed in the surface region of collagen=
apatite composite or apatite alone can switch on the remo-
deling cascade.87–89 Osteocalcin present in solution (and thus
also on the surface) inhibits the nucleation and growth of
apatite crystals in vitro,27,50,65 and the presence of Gla is
crucial.50 But osteocalcin is probably more important for re-
modeling than for nucleation45 due to its late appearance
during bone formation.
Preadsorbed dentin matrix protein 1 induces apatite for-
mation on glass plates in vitro.90 Some domains undergo a
shift to b-sheet conformation upon Ca binding that precedes
mineralization.91 The b-sheets are also proposed to act as
templates for mineralization.73 It would seem that the Ca ion
binding also acts as an electrostatic shield that is important
for this change in conformation.
Phosphophoryn in the mineralized dentin matrix is highly
phosphorylated.40 It is believed to be involved in the regu-
lation of the mineralization processes by binding to colla-
gen, nucleating mineralization, and controlling crystal
growth,40,61,92–95 and inhibits seeded growth.34
There are many proteins that are not specific for bone
tissue that also take part in the formation of bone especially if
they are present in the blood stream. Fibronectin and vitro-
nectin modulate and induce de novo growth of apatite crystals
when adsorbed, but inhibits apatite growth when adsorbed
on already formed apatite.96 Apparently, adsorbed fibrinogen
and albumin may have different effects on mineralization
depending on the substrate97,98 that perhaps differently af-
fect their conformation upon adsorption and also their ability
to affect mineralization. The type of seed crystal has shown
to be important when phosphoproteins are dissolved.34 This
could be due to differences in ability to adsorb to the sur-
faces. Secondary structure of a protein can be important for
its ability to induce apatite formation after adsorption,61,99
perhaps by providing a stiff template or chelator as starting
point for nucleation.
Most of the reported posttranslational modifications that
impact on the mineralization modulation ability of proteins
are covered in the Supplemental Material. Overall, most of
the proteins that induce or inhibit apatite nucleation and=or
growth contain clusters of negatively charged groups like
sulfate, carboxyl, and phosphate that act via electrostatic
interaction to attract or coordinate calcium ions at apatite
surfaces, in solution and adsorbed.
Ectopic mineralization
Mineralization in soft tissue is in most case not functional
and can be lethal especially if it persists in the arteries. So an
active control seems to be of vital importance. To curb ec-
topic mineralization there are a number of control proteins
such as matrix Gla protein,42,100 osteopontin,40,101,102 and
statherin.48,64,103,104 The sulfated saccharides on soft tissue
proteoglycans have been suggested to play the role as in-
hibitors although the mechanism still is not clear. Also, as
mentioned earlier serum and albumin can delay and=or in-
hibit nucleation and growth.
Bone Gla protein and osteonectin, but not the Ca2þ bind-
ing proteins calmodulin and parvalbumin, inhibit in vitro
growth of hydroxylapatite.50,100 It was suggested that the
conformation for binding to apatite was not favorable for the
latter two proteins. Thus, Ca2þ binding by itself may not
always be a good marker for which proteins control apatite
formation. Notably, negatively charged amino acid motifs
are important in both ectopic and topical mineralization.
Adsorbed versus dissolved
Experimental models with either dissolved or adsorbed
proteins have been used to elucidate if certain proteins act as
inhibitors or promoters of mineralization. In many cases pro-
teins that act as inhibitors of apatite nucleation and growth
when dissolved also act as promoter of mineralization when
adsorbed.16,22,85,98,105–113 But for the case of bone and dentin
most of the matrix proteins are not in solution.34,114 It has
been suggested that a difference in conformation for proteins
as dissolved and adsorbed can account for some of the ob-
served differences in behavior with regard to apatite for-
mation.50 Preadsorption of proteins could lead to induction
of mineralization if the mineralization-modulating proteins
are in an appropriate conformation. Further, some proteins
probably can bind to already formed mineral nuclei and
thus stabilize them for further growth,16 inhibit dissolution,115
or inhibit further growth.104
The adsorbed proteins may in different ways affect min-
eralization caused by the change in interfacial energy after
the protein adsorption. It has been suggested that proteins
when adsorbed on any surface can promote nucleation, but
when adsorbed on already formed crystals they may de-
crease further crystal growth.96,105 It has also been suggested
that nonspecific protein adsorption decreases the substrate–
liquid surface tension and thus lower the nucleation ability of
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the substrate surface9 but might mostly be an effect on non-
inducing proteins covering the surface.
Concentration of protein
Along the in vivo timeline of mineralization, the presence
of proteins will change also their concentration. Protein-
induced mineral nucleation in solution decreases the amount
of free ions and thus can drive the solution below (super)
saturation and thus affect the ability of already started apa-
tite formation to grow further. In the same manner Ca2þ-
chelating proteins in solution will increase the dissolution of
already formed apatite crystals. Although some proteins can
bind calcium when dissolved, it is also possible that their
adsorption on specific apatite faces will inhibit or direct ap-
atite growth.116
Apatite mineralization in vitro is increasingly inhibited with
an increasing concentration of serum solution, most likely
because the adsorbed proteins block further growth117–119 but
can also lead to differences in morphology of crystal coatings
after mineral growth on a variety of calcium phosphates.120
Human serum albumin has been pointed out as an important
factor in this process,118 but also the biopolymers that bind to
different sites on apatite are more effective together at in-
hibiting apatite growth.121 The effect of proteins on apatite
growth and transformation depends not only on the proteins
but also on the seed crystals. Overall, serum proteins are as-
sumed to impede de novo formation of apatite but may not
always hinder seeded growth.122
For many mineralization-related proteins, it has been found
that they induce growth when dissolved in small amounts, but
at a certain point they start to inhibit further growth of hy-
droxylapatite.27,63,84,123,124 Each of these in vitro effects has been
attributed to interactions between the protein and specific
faces of apatite. Combes and Rey have proposed that at low
protein concentrations nucleation and growth are not much
inhibited, but at higher concentrations adsorbed protein will
inhibit growth (rather than nucleation) to such an extent that
the overall mineral formation is inhibited.9
Proteins and Polypeptides in Making
Mineralized Constructs
There is a very extensive body of research aimed at making
use of oligo- or polypeptides for modulating cell attachment
and growth, but so far the specific use of (poly)peptides aimed
at acellular induction and modulation of apatite formation for
use in bone tissue engineering applications is more sparse.
In the following sections, we will highlight and comment on
some more recent results from the use of proteins and peptides
for making mineralized biomaterials and biomaterials that
promote (acellular) mineralization.
Blends of Mineral and Proteins
There is a vast body of research on mixing proteins or
peptides with apatite particles to make mineralized bioma-
terials. The aim is not necessarily to impose properties on the
apatite particles themselves but rather to make composites in
which apatite particles are immersed in an organic matrix,
often in an attempt to mimic bone matrices, but very often
not aiming to use the ability of the polypeptides to induce or
modulate mineralization.
The success of composites of fibrin sealant and ceramic
in vivo has been reported to be ambiguous, but in some cases
they were able to induce the formation of woven bone.153
Because the bone remodeling will transform the woven bone
into lamellar bone,11 it might be of interest to aim at making
scaffolds that at first induce formation of woven bone in vivo
rather than lamellar bone.
There have been some studies of making collagen–mineral
composites154–156 aimed at inducing bone repair. This type of
matrix can readily be loaded with growth promoters for a wide
variety of cells. This approach also benefits from the seeded
growth in vivo that is less susceptible to interference from ad-
sorbing proteins with regard to crystal growth. The main
drawback is the nonautograft collagen with all the accompa-
nying issues regarding disease transmission and immunore-
jection. The use of synthetic and biodegradable polymers that
would provide a 3D network similar to that of collagen would
hopefully circumvent those problems.
In a recent study of a collagen hydrogel aimed at soft tis-
sue repair, it was suggested that calcium phosphate should
be included157 because it has been suggested that Ca2þ ions
are necessary for neurite growth.158 Thus such ions released
from the scaffolds also would improve neurite healing.157
Indeed, a premineralized structure perhaps could also act as
a reservoir of ions to promote mineralization. Also, it has
earlier been suggested that because elevated ion concentra-
tions are needed for apatite formation, dissolution of already
formed or coated apatite will help to maintain the local ion
concentrations at elevated levels.159
Hydrogels
A synthetic self-assembling oligopeptide (Ace-Gln-Gln-
Arg-Phe-Glu-Trp-Glu-Phe-Glu-Gln-Gln-NH2) that forms b-
sheet fibrils has been shown to promote healing of dental
lesions. Two potential nonexclusive mechanisms were pro-
posed; the peptides form a gel that acts as Ca ion chelator
and=or it acts to inhibit apatite dissolution in the acidic oral
environment.160 This study points to the possibility of re-
pairing small defects in mineralized tissues with a gel struc-
ture that itself is not initially mineralized. To some extent this
has already been achieved without polypeptide gels when
the damaged section of bone has been delimited by a mem-
brane barrier,161,162 but gelatin foams might impede healing
by obstructing bone marrow growth163 although the authors
comment on the possible use of bone inductive components
to overcome this problem for large (even critical sized) bone
defects.
The hydrophobic and basic P15 sequence (GTPGPQGIA
GQRGVV) from collagen has been shown to bind to apatite
particles. P15-coated apatite particles better induce bone
formation when immersed in hydrogels and injected in vivo
than just the apatite.164,165 This again stresses the usefulness
of (synthetic) oligopeptides, but also when load bearing is not
an immediate essential requirement that injectable hydrogel=
apatite composites could have a positive effect on bone for-
mation.
Polypeptide Coatings
There are some approaches to drug delivery that make
use of calcium phosphates; the drug is either present during
the mineral preparation166,167 or later adsorbed onto the
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mineral168–170 and also bone morphogenetic protein (BMPs).171
One would expect that the former approach will enable a
higher load and also a prolonged release. One could possibly
alter the release kinetics by adding polypeptides to the outer
surface of the apatite particles to make the mineral degrade
slower or with a delayed onset of dissolution. This shows that
the mineral phase of tissue engineering constructs also could be
used as drug delivery devices. One study showed prolonged
drug release by coating the mineral particles with albumin,170
but it is not clear if it is due to prolonged release of the adsorbed
protein or because the mineral is degraded slower, although it
has been shown that proteins adsorbed to apatites will delay
their dissolution.103,115
Electrodeposition of amelogenin promotes ordered apatite
mineralization in vitro and has been suggested as a way to
produce mineralized constructs.172 Perhaps it would be in-
teresting if this approach could be translated in vivo, that is,
for repair of decayed enamel by using a chimeric approach
with one end binding to the existing enamel and the other
inducing enamel repair.
Further, as noted in a recent review, phosphorylation of
synthetic polymers could be a way to mimic phosphorylated
proteins in how they promote mineralization.173 This would
avoid much of the problems associated with allogenic pro-
teins whilst being applicable to a wide variety of polymers.
Although one would again expect that conformation is an
important issue to assure proper mineralization.
Proteins Coprecipitated with Mineral
As noted above there is a difference between coating an
apatite and having the organic phase incorporated during the
fabrication of the apatite itself, either as particles or coating
on devices. By having polypeptides or proteins present
during mineralization in vitro, it is possible to affect the
morphology of the formed apatite.174–177 In many cases this
type of incorporation of proteins or peptides into an apatite
matrix will make the apatite less crystalline and thus also
more susceptible to degradation by dissolution, although the
mechanical strength could be improved by incorporating pro-
teins.177 Apatite in bone is more easily dissolved than synthe-
tic hydroxylapatite.7,178,179 Perhaps this is an desired starting
point because the aim is to have the mineralized scaffolds
being subjected to bone remodeling, which includes resorp-
tion of the initial apatite.180 To some extent this has been
achieved by a matrix of collagen and apatite nanoparticles
that was shown to induce processes of bone degradation
and formation that is similar of bone remodeling 176,181,182
although the formed bone was not hierarchical.
By adding a phosphoprotein to collagen, one can induce
apatite formation in vitro,183 but because of the nonautograft-
related problems, it might be better to aim for recombinant
collagen.83 However, the incorporated protein could im-
prove the mineral phase by conveying a function such as
improvement of degradation kinetics of the polymer sub-
strate174,175 or adherence or stimulation of bone forming
cells184,185 (see also above paragraphs on drug delivery in the
Peptide Coatings section).
Even much simpler molecules such as peptides and
polypeptides have been used to form apatitic constructs.
Coprecipitation with monomeric peptides has been shown to
have potential to make apatite nanoparticles that in turn can
be mixed with dextran sulfate to make 3D sponges. Aspartic
acid was shown to be more successful than both arginine and
lysine in making the sponge and getting the best cellular
response to the hybrid although the scaffold was deemed too
weak to be suitable for load-bearing applications.186
Acidic peptides have been combined with hydrophobic
groups (peptides or alkyls) to produce self-assembled nano-
fibers to be used for inducing mineralization,187–189 perhaps as
a new class of injectable systems69 that perhaps are better
suited for small rather than critical-size defects.190 Nanofibers
made with amphiphiles with alkyl groups in the hydrophobic
tail and serine or phosphoserine near the hydrophilic terminal
gave amorphous deposits and apatite, respectively.189 No-
tably, in the latter case the crystals were oriented along the
fibers. A similar system with phosphoserine promoted apatitic
mineralization when coated on titanium.191 Amphiphiles with
only peptides with aspartic acid in the hydrophilic tail that
also forms nanotubular fiber meshes192 could probably also act
as an organic matrix for mineralization.193
Chimeric Peptides
Some effort has been made to make protein or oligopep-
tide coatings on either apatite particles or apatite coatings to
enhance cell response. Synthetic polypeptides that use specific
functionalities from more than one parent protein could be
used in tissue engineering applications for inducing bone for-
mation.194 For example, one part binds to already formed
apatite and the second is used as a cell-binding ligand. Indeed,
many of the apatite-binding proteins also have domains with
an arginine-glycine-aspartic acid (RGD) or other cell-binding
ligands.194 It has been suggested that by combining apatite-
nucleating domains from one protein and cell-binding domain
from another, one can induce desired function in biomedical
applications.126 The apatite-binding domain from pig bone
sialoprotein was combined with the collagen-binding site of
decorin into a chimeric protein. This chimer was bound to
collagen and was found to induce apatite formation.126 Gilbert
et al. used a similar approach using the N15 terminal from
statherin and an RGD containing hexapeptide from osteo-
pontin,195 which mediated a dose-dependent adhesion of
melanoma cells but not without the hexapeptide. An even
more downscaled approach is to attach an RGD sequence to a
septa-glutamic acid.196 The glutamic acid residue bound to the
apatite, and the RGD sequence attracted mesenchymal stem
cells more effectively than the RGD without the septa-Glu. A
recent study has cast a doubt on this type of approach because
it was claimed that since apatite is so prone to protein ad-
sorption, any preattached cell ligands will be covered by an
array of blood proteins,197 although the approach still could be
useful to improve cell seeding prior to implantation.
There already are chimeric proteins in the body because
many of the bone matrix proteins bind to collagen and have
sites for apatite formation or osteoblast attachment—for exam-
ple, osteonectin49 and bone sialoprotein.198,199 The use of syn-
thetic chimeric polypeptides could very well be a way to avoid
the xeno=allograft–related problems while tailoring specific
polypeptides for tissue engineering approaches. In the case of
bone tissue engineering, the chimeric approach might be use-
ful for coating or loading of ex vivo formed apatite constructs.
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Concluding Remarks
The remaining crux is to determine if protein–apatite
(coated) scaffolds can have a positive effect on apatite forma-
tion in vivo under the interference from blood proteins and
surrounding tissue, and ultimately lead to new bone forma-
tion and remodeling in the implantation site. The polymeric
scaffold that is intended as a template for apatite formation
does not necessarily have to fulfill the ratios of mineral-to-
organic phase of mature bone because the aim of tissue en-
gineering is to create a starting point for the human body so
that remodeling or healing is promoted. Ideally, the poly-
meric peptide (coated) scaffold should also be tailored for
angiogenesis and a host of other characteristics.
Proteins are natural and necessary components of the mi-
neralization of bone apatite in vivo. Taking the step of using
(synthetic) proteins or protein fragments to induce apatite for-
mation is thus very appealing. Such elements could be used
in the preparation of scaffolds for enhancing the apatite mi-
neralization process that leads to bone formation.
Because there are so many proteins that affect the mecha-
nical, biochemical, and physicochemical properties of the
formed apatite, by using proteins or well-designed fragments
it should be possible to
 induce nucleation,
 induce and modulate growth,
 incorporate polypeptides or proteins during apatite
growth that yield properties that can induce bone re-
modeling and vascularization, and
 coat the apatite with polypeptides that induce appro-
priate cell attachment and remodeling, and modulation
of mineral dissolution.
The idea is thus to make use of a combination of strategies
to achieve a good starting point for the bodily responses to
take over so that the engineered scaffold can be transformed
into mature bone.
For the future we already now see an increasing trend in
borrowing traits from various mineralization-related pro-
teins (rather than the whole protein) and applying them for
tailored mineralization on scaffolds that should lead to min-
eral phase for its intended function or for such that miner-
alization is better avoided. One would perhaps also expect
more computer modeling of existing apatite-binding domains
to determine more completely how proteins interact with
apatite surface and ions in solution, and compare those
findings with structural matching between apatite and novel
oligopeptides. Current trends and advances in oligo- and
polypeptide design and synthesis promise a very high de-
gree of control of end product that in the end could be useful
in improving the mineralization characteristics of emerging
multifunctional bone tissue engineering scaffolds.
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